Thestructure of a newantibiotic verucopeptin has been determined by the spectroscopic analyses and chemical degradation studies. It is a 1 9-memberedcyclodepsipeptide which is structurally related to azinothricin and A83586C.
Actinomadura verrucosospora Q886-2 produced a new antitumor antibiotic verucopeptin1) which showed specific in vivo activity against B16 melanoma. The producing organism, fermentation isolation, physico-chemical and biological properties of the antibiotic were reported in the previous paper2). This paper describes the structure elucidation of verucopeptin. General Characteristics Verucopeptin (1) was isolated as a white amorphous powder. The molecular formula of 1 was determined to be C43H73N7O13on the basis of elemental analysis and HRFAB-MS data (m/z 894.5217 (M-H)~). The IR spectrum of 1 showeda strong absorption at 1640 cm" 1 suggesting a peptidic structure for the antibiotic. An absorption at 1750 cm" * which disappeared upon treatment of0. 1 n sodium hydroxide suggested the presence of an ester (or a lactone) in the molecule. Acid hydrolysis of 1 with 6 n hydrochloric acid gave three amino acids, glycine (1 mole), sarcosine (2 moles) and /Miydroxyleucine (1 mole) along with an unseparable mixture of lipophilic fragments. In the XHNMRspectrum, all the proton and carbon signals of 1 were observed as double peaks with 4: 1 ratios, which made the structural elucidation of 1 by NMRanalyses difficult. In the 13C NMR spectrum, 1 showed two exchangeable carbon signals at S 98.4 (main) and S 21 1.2 (minor) which suggested a hemiketal and ketone form structure, respectively. NaBH4 Reduction 1 was treated with NaBH4in methanol to afford two reduction products (2a and 2b) which were separated by reversed phase column chromatography. The same molecular ion peak at m/z 896 (M -H)w as obtained in negative FAB-MSspectra of 2a and 2b, but they were differentiated by TLCand HPLC. Their IR and XHNMRare nearly identical indicating them to be stereo-isomers produced by NaBH4 reduction of the ketone moiety. The 13C NMRspectra of 2a (Table 1 ) displayed 43 well-resolved carbons whichwere analyzed as CH3 x8, CH2 x 12, CHx6, N-CH3 x2, O-CH3, XX O-CHx4, C=CH(S 131.7 Table 1 . 13C NMRdata of verucopeptin (1), reduction (2a) and degradation products (3, 4 (Table 2 ) revealed the presence of two amide protons (3 7.05d and 7.14brs) and two D2O-exchangeable protons (3 4.78 d and 9.21 s) in addition to all the protons expected from the 13C NMRspectrum. These spectral data indicated that 2a is related to azinothricin3) and A83586C4). The detailed NMRanalyses assisted by WH,^-^C and^-^C long range COSYspectra revealed the following seven structural units (a~g) in 2a. The presence of sarcosines (a, c), glycine (b) and /Miydroxyleucine (f) was confirmed and two unusual amino acid, 7V-hydroxyglycine (d) and piperazic acid (e) were assigned as shown in Fig. 1 by comparison with the spectra of A83586C.The structure of acyl side chain (g) was elucidated by 2D NMRtechniques.
Alkaline Hydrolysis of Reduction Product 2b 2b was heated with 1.0n sodium hydroxide at 100°C for 1 hour and the hydrolysate was treated with diazomethane. The product was purified by silica gel chromatography followed by preparative HPLCto afford degradation products 3, 4 and 5. In the negative FAB-MSspectra, 3, 4 and 5 showed molecular ion peaks at m/z 472, 584 and 544 (M -H)~, respectively. The molecular formulae of these compounds were estimated to be C25H47NO7 for 3, C3oH55N308 for 4 and C29H55NO8 for 5, by FAB-MS and 13C NMRspectra and their structures were determined as shown in Fig. 2 on the basis of the spectral analyses. A glycine residue is present in 3 and 4 instead of /Miydroxyleucine contained in the original compound (2b) and 5. This indicated that the retro-aldol reaction occurred at the /Miydroxyleucine moiety during the alkaline hydrolysis. Compounds3, 4 and 5 clarified the connectivities of the structural units establishing the sequence from C-7 to C-43 in 2a. Recorded at 400MHzin CDC13: ppm from solvent peak at S 7.26.
Structures of 1 and 2 The linkages of the remaining units were determined by 1H-13C long range COSYand NOESY spectral analyses as shown in Fig. 3 . Two TV-methyl protons and an amide proton displayed contours with following their relevant carbons, 20-CH3 (C-2 and C-3), 21-CH3 (C-6 and C-7) and 4-NH (C-5) to establish the linkage from C-l to C-8. The NOEwas observed between 7V-hydroxyl proton (^9.21) and the a-methine proton at 10-H (S 5.23), which indicated that C-9 carbonyl group binds to the 7V-hydroxyglycine by an amide linkage. The a-methine proton of /Miydroxyleucine (16-H, 3 4.92) showed a correlation with the ester carbonyl carbon (C-l,^168.5) establishing a unique 19-membered cyclodepsipeptide ring (C-l to C-16). Thus the structure of 2a was determined as shown in Fig. 3 . As described before, 1 exists as a mixture of two isomers in solution, and all the signals in the NMR spectra were observed as double peaks with 4 : 1 ratios. The main carbon signals of 1 were assigned as shown in Table 1 in comparison with 2a. The C-24 carbon signal at 3 98.4 (80%) is interchangeable to signal at 3 211.2 (20%) suggesting that 1 formed the same hemiketal ring as A83586C between C-24 and C-28 and apart of1 existed as a ketone formin solution. Thus, the structure of1 is now shown in Fig. 4 .
Discussion
The structure of verucopeptin has been determined based on the spectral analyses and degradation experiments. It is structurally related to azinothricin3), A83586C4), variapeptin5'6), citropeptin5>7) and L-1 56,6028) which are 19-membered cyclodepsipeptides containing piperazic acids, /Miydroxyleucine and TV-hydroxy-amino acid. Verucopeptin clearly differs from these antibiotics in having only one mole of piperazic acid and the presence of glycine and sarcosine. Furthermore, the acyl side chain conjugated to the hemiketal ring is considerably different from those of the known antibiotics. It is also worth to note that verucopeptin showedspecific in vitro and in vivo inhibition against mouse B16melanomaand weak or no antibacterial activity, while all the other structurally related antibiotics were reported to show strong inhibitory activity against Gram-positive bacteria in addition to weak cytotoxicity.
Experimental
General TLC was performed on precoated silica gel plates (Kieselgel 60F254, Merck). IR spectra in KBr discs 
were recorded on a Jasco IR-810 spectrophotometer and UVspectra on a UVIDEC-610C spectrometer. *H and 13C NMRspectra were measured on a JEOL JNM-GX400 spectrometer. FAB-MSspectra were obtained on a JEOL JNM-AX 505H mass spectrometer.
Complete Acid Hydrolysis of 1 1 (300mg) dissolved in 6n HC1 (15ml) was heated in a sealed tube for 16 hours at 105°C. After addition of water (90 ml), the reaction mixture was extracted with ethyl ether (50ml x 2). Evaporation of the ethyl ether extract afforded an oily residue (90 mg) containing unidentified lipophilic fragments. The aqueous layer was concentrated in vacuo to a sticky solid (240mg) which was applied on a column of Dowex50W x 4 (pyridine form, 1.5 i.d. x 75cm). The column was developed with 0.1 m pyridine-formic acid (pH 3.1) and 0.2m pyridine-formic acid (pH 3.1) successively and the eluate was monitored by TLC A suspension of2b (130mg) in aqueous 1 n NaOH(13ml) was heated at 100°C for 1 hour in a sealed tube. The reaction mixture was diluted with water (150 ml), acidified with 1 n HC1(pH 2.0) and extracted by BuOH(150 ml x 2). The solvent extract was concentrated to a residue which was dissolved in a mixture of CH2Cl2-MeOH (9 : 1, 2ml) and reacted with large excess of CH2N2in ether. After concentration of the reaction mixture, the residue was dissolved in EtOAc (100ml) and shaken with water (100ml). The organic layer was separated and concentrated in vacuo to yield a hydrolysate (80 mg) which showed mainly Table 2 .
